420 related articles for article (PubMed ID: 29456214)
1. Outcome of renal transplant recipients with cytomegalovirus and BK polyomavirus co-infection nephropathy.
Kaul A; Kumar S; Bhaduaria D; Agrawal V; Sharma RK; Prasad N; Gupta A; Kumar R
Saudi J Kidney Dis Transpl; 2018; 29(1):101-106. PubMed ID: 29456214
[TBL] [Abstract][Full Text] [Related]
2. Different behaviour of BK-virus infection in liver transplant recipients.
Umbro I; Tinti F; Muiesan P; Mitterhofer AP
World J Gastroenterol; 2016 Jan; 22(4):1532-40. PubMed ID: 26819520
[TBL] [Abstract][Full Text] [Related]
3. Viral infections directly involved in kidney allograft function.
Masutani K
Nephrology (Carlton); 2018 Jul; 23 Suppl 2():31-37. PubMed ID: 29968408
[TBL] [Abstract][Full Text] [Related]
4. Viral Origin, Clinical Course, and Renal Outcomes in Patients With BK Virus Infection After Living-Donor Renal Transplantation.
Schwarz A; Linnenweber-Held S; Heim A; Framke T; Haller H; Schmitt C
Transplantation; 2016 Apr; 100(4):844-53. PubMed ID: 26720302
[TBL] [Abstract][Full Text] [Related]
5. CMV and BKPyV Infections in Renal Transplant Recipients Receiving an mTOR Inhibitor-Based Regimen Versus a CNI-Based Regimen: A Systematic Review and Meta-Analysis of Randomized, Controlled Trials.
Mallat SG; Tanios BY; Itani HS; Lotfi T; McMullan C; Gabardi S; Akl EA; Azzi JR
Clin J Am Soc Nephrol; 2017 Aug; 12(8):1321-1336. PubMed ID: 28576905
[TBL] [Abstract][Full Text] [Related]
6. Screening for BK Viremia/Viruria and the Impact of Management of BK Virus Nephropathy in Renal Transplant Recipients.
Zakaria ZE; Elokely AM; Ghorab AA; Bakr AI; Halim MA; Gheith OA; Nagib AM; Makkeyah Y; Balaha MA; Magdy MM; Al-Otaibi T
Exp Clin Transplant; 2019 Jan; 17(Suppl 1):83-91. PubMed ID: 30777529
[TBL] [Abstract][Full Text] [Related]
7. Correlation of BK Virus Neutralizing Serostatus With the Incidence of BK Viremia in Kidney Transplant Recipients.
Abend JR; Changala M; Sathe A; Casey F; Kistler A; Chandran S; Howard A; Wojciechowski D
Transplantation; 2017 Jun; 101(6):1495-1505. PubMed ID: 27854236
[TBL] [Abstract][Full Text] [Related]
8. BK Virus in Renal Transplant Patients Using Alemtuzumab for Induction Immunosuppression.
Korneffel K; Gehring B; Rospert D; Rees M; Ortiz J
Exp Clin Transplant; 2020 Oct; 18(5):557-563. PubMed ID: 31324134
[TBL] [Abstract][Full Text] [Related]
9. Long-Term Follow-Up of Active Treatment Versus Minimization of Immunosuppressive Agents in Patients With BK Virus-Associated Nephropathy After Kidney Transplant.
Halim MA; Al-Otaibi T; Gheith O; Mosaad A; Zakaria Z; Said T; Nair P; Nampoory NM
Exp Clin Transplant; 2016 Feb; 14(1):58-65. PubMed ID: 26862825
[TBL] [Abstract][Full Text] [Related]
10. Elimination of BK viremia in renal transplant recipients by optimization of immunosuppressive medications without precipitating acute rejection.
Jha A; Ahmed W; Pakkyara A; Shaheen F; Al Salmi I
Saudi J Kidney Dis Transpl; 2018; 29(5):1073-1081. PubMed ID: 30381503
[TBL] [Abstract][Full Text] [Related]
11. Management of BK virus nephropathy in kidney transplant recipients at the Royal Hospital - Clinical Audit - Oman.
Al-Raisi F; Mohsin N; Kamble P
Exp Clin Transplant; 2015 Apr; 13 Suppl 1():156-8. PubMed ID: 25894146
[TBL] [Abstract][Full Text] [Related]
12. 25-hydroxyvitamin D deficiency and opportunistic viral infections after kidney transplant.
Rech MA; Fleming JN; Moore CL
Exp Clin Transplant; 2014 Apr; 12(2):95-100. PubMed ID: 24702139
[TBL] [Abstract][Full Text] [Related]
13. Differential Diagnosis of Interstitial Allograft Rejection and BKV Nephropathy by T-cell Receptor Sequencing.
Stervbo U; Nienen M; Hecht J; Viebahn R; Amann K; Westhoff TH; Babel N
Transplantation; 2020 Apr; 104(4):e107-e108. PubMed ID: 32224816
[No Abstract] [Full Text] [Related]
14. BK Virus in Kidney Transplant: Current Concepts, Recent Advances, and Future Directions.
Sharma R; Tzetzo S; Patel S; Zachariah M; Sharma S; Melendy T
Exp Clin Transplant; 2016 Aug; 14(4):377-84. PubMed ID: 27267780
[TBL] [Abstract][Full Text] [Related]
15. Risk factors in the progression of BK virus-associated nephropathy in renal transplant recipients.
Lee HM; Jang IA; Lee D; Kang EJ; Choi BS; Park CW; Choi YJ; Yang CW; Kim YS; Chung BH
Korean J Intern Med; 2015 Nov; 30(6):865-72. PubMed ID: 26552462
[TBL] [Abstract][Full Text] [Related]
16. Co-existence of BKV nephropathy and disseminated tuberculosis in transplant recipient.
Al-Warthan S; Al-Hwiesh A
Saudi J Kidney Dis Transpl; 2014 Sep; 25(5):1046-50. PubMed ID: 25193905
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and Risk Factors of BK Viremia and Clinical Impact of BK Virus Surveillance on Outcomes in Kidney Transplant Recipients: A Single-Center Cross-Sectional Study.
Ji J; Feng S; Jiang Y; Wang W; Zhang X
Exp Clin Transplant; 2019 Dec; 17(6):727-731. PubMed ID: 30995893
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous monitoring of CMV and BKV by quantitative PCR in renal transplant recipients.
Wu CZ; Chen XQ; Wang ZY; Pan XD; Bai YH; Yang YR; Zheng SL; Xia P
J Virol Methods; 2014 Dec; 210():40-4. PubMed ID: 25261811
[TBL] [Abstract][Full Text] [Related]
19. BK Virus nephropathy in living donor renal allograft recipients: An observational study from a large transplant center in India.
Gupta P; Gupta A; Bhalla AK; Malik M; Gupta A; Bhargava V; Rana DS
Saudi J Kidney Dis Transpl; 2018; 29(6):1366-1370. PubMed ID: 30588968
[TBL] [Abstract][Full Text] [Related]
20. Temporal serum creatinine increase and exacerbation of tubulointerstitial inflammation during the first two months in resolving polyomavirus BK nephropathy.
Masutani K; Tsuchimoto A; Matsukuma Y; Kurihara K; Nishiki T; Kitada H; Tanaka M; Kitazono T; Tsuruya K
Nephrology (Carlton); 2015 Jul; 20 Suppl 2():45-50. PubMed ID: 26031586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
